Literature DB >> 25624344

Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma.

Fang-Fang Zheng1, Li-Min Zhu1, Ai-Fang Nie1, Xiao-Ying Li1, Jing-Rong Lin1, Ke Zhang1, Jing Chen1, Wen-Long Zhou1, Zhou-Jun Shen1, Yi-Chun Zhu1, Ji-Guang Wang1, Ding-Liang Zhu1, Ping-Jin Gao2.   

Abstract

Recent studies have shown that somatic mutations in the KCNJ5, ATP1A1, ATP2B3, and CACNA1D genes are associated with the pathogenesis of aldosterone-producing adenoma. Clinical profile and biochemical characteristics of the mutations in Chinese patients with aldosterone-producing adenoma remain unclear. In this study, we performed DNA sequencing in 168 Chinese patients with aldosterone-producing adenoma and found 129 somatic mutations in KCNJ5, 4 in ATP1A1, 1 in ATP2B3, and 1 in CACNA1D. KCNJ5 mutations were more prevalent in female patients and were associated with larger adenomas, higher aldosterone excretion, and lower minimal serum K(+) concentration. More interestingly, we identified a novel somatic KCNJ5 mutation (c.445-446insGAA, p.T148-T149insR) that could enhance CYP11B2 mRNA upregulation and aldosterone release. This mutation could also cause membrane depolarization and intercellular Ca(2+) increase. In conclusion, somatic KCNJ5 mutations are conspicuously more popular than mutations of other genes in aldosterone-producing adenomas of Chinese patients. The T148-T149insR mutation in KCNJ5 may influence K(+) channel selectivity and autonomous aldosterone production.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  KCNJ5; aldosterone; hypertension; potassium channel; somatic mutation

Mesh:

Substances:

Year:  2015        PMID: 25624344     DOI: 10.1161/HYPERTENSIONAHA.114.03346

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  53 in total

Review 1.  Familial hyperaldosteronism type III a novel case and review of literature.

Authors:  Natividad Pons Fernández; Francisca Moreno; Julia Morata; Ana Moriano; Sara León; Carmen De Mingo; Ángel Zuñiga; Fernando Calvo
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

Review 2.  The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

Authors:  Anand Vaidya; Paolo Mulatero; Rene Baudrand; Gail K Adler
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

Review 3.  [Primary aldosteronism : Genetics and pathology].

Authors:  U Scholl
Journal:  Pathologe       Date:  2019-12       Impact factor: 1.011

4.  A Novel Somatic Deletion Mutation of ATP2B3 in Aldosterone-Producing Adenoma.

Authors:  Masanori Murakami; Takanobu Yoshimoto; Isao Minami; Ryotaro Bouchi; Kyoichiro Tsuchiya; Koshi Hashimoto; Hajime Izumiyama; Yasuhisa Fujii; Takashi Endo; Takumi Akashi; Koshiro Nishimoto; Kuniaki Mukai; Kazunori Kihara; Yoshihiro Ogawa
Journal:  Endocr Pathol       Date:  2015-12       Impact factor: 3.943

Review 5.  Steroid Profiling and Immunohistochemistry for Subtyping and Outcome Prediction in Primary Aldosteronism-a Review.

Authors:  Finn Holler; Daniel A Heinrich; Christian Adolf; Benjamin Lechner; Martin Bidlingmaier; Graeme Eisenhofer; Tracy Ann Williams; Martin Reincke
Journal:  Curr Hypertens Rep       Date:  2019-09-03       Impact factor: 5.369

6.  Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth.

Authors:  Yuhong Yang; Celso E Gomez-Sanchez; Diana Jaquin; Elke Tatjana Aristizabal Prada; Lucie S Meyer; Thomas Knösel; Holger Schneider; Felix Beuschlein; Martin Reincke; Tracy Ann Williams
Journal:  Hypertension       Date:  2019-08-26       Impact factor: 10.190

7.  Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks.

Authors:  Kazutaka Nanba; Kei Omata; Celso E Gomez-Sanchez; Constantine A Stratakis; Andrew P Demidowich; Mari Suzuki; Lester D R Thompson; Debbie L Cohen; James M Luther; Lan Gellert; Anand Vaidya; Justine A Barletta; Tobias Else; Thomas J Giordano; Scott A Tomlins; William E Rainey
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

8.  Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations.

Authors:  Kazutaka Nanba; Kei Omata; Scott A Tomlins; Thomas J Giordano; Gary D Hammer; William E Rainey; Tobias Else
Journal:  Eur J Endocrinol       Date:  2016-05-10       Impact factor: 6.664

9.  Cellular and Genetic Causes of Idiopathic Hyperaldosteronism.

Authors:  Kei Omata; Fumitoshi Satoh; Ryo Morimoto; Sadayoshi Ito; Yuto Yamazaki; Yasuhiro Nakamura; Sharath K Anand; Zeng Guo; Michael Stowasser; Hironobu Sasano; Scott A Tomlins; William E Rainey
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

10.  Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype.

Authors:  Ute I Scholl; James M Healy; Anne Thiel; Annabelle L Fonseca; Taylor C Brown; John W Kunstman; Matthew J Horne; Dimo Dietrich; Jasmin Riemer; Seher Kücükköylü; Esther N Reimer; Anna-Carinna Reis; Gerald Goh; Glen Kristiansen; Amit Mahajan; Reju Korah; Richard P Lifton; Manju L Prasad; Tobias Carling
Journal:  Clin Endocrinol (Oxf)       Date:  2015-09-23       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.